FNDC5 and metabolic syndrome: The irisin levels were also significantly higher in subjects without metabolic syndrome compared to those with metabolic syndrome (1.91 ± 0.92 μg/mL without metabolic syndrome and 1.78 ± 0.80 μg/mL with metabolic syndrome, P = 0.03; data not shown).